Chesley Taft & Associates’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,915
Closed 302
2022
Q1
$0 Hold
11,915
﹤0.01% 311
2021
Q4
$0 Hold
11,915
﹤0.01% 304
2021
Q3
$0 Hold
11,915
﹤0.01% 302
2021
Q2
$0 Hold
11,915
﹤0.01% 294
2021
Q1
$0 Hold
11,915
﹤0.01% 296
2020
Q4
$0 Hold
11,915
﹤0.01% 290
2020
Q3
$0 Hold
11,915
﹤0.01% 270
2020
Q2
$0 Hold
11,915
﹤0.01% 265
2020
Q1
$0 Hold
11,915
﹤0.01% 272
2019
Q4
$0 Sell
11,915
-7,900
-40% ﹤0.01% 272
2019
Q3
$0 Hold
19,815
﹤0.01% 274
2019
Q2
$0 Hold
19,815
﹤0.01% 263
2019
Q1
$9K Hold
19,815
﹤0.01% 253
2018
Q4
$24K Hold
19,815
﹤0.01% 251
2018
Q3
$79K Hold
19,815
0.01% 276
2018
Q2
$172K Buy
19,815
+1,740
+10% +$21.2K 0.01% 268
2018
Q1
$234K Buy
+18,075
New +$205K 0.02% 254

Chesley Taft & Associates's AKAO Position: Q2 2022 in Review

Chesley Taft & Associates sold out of Achaogen Inc (AKAO) in Q2 2022, closing a stake of 11,915 shares.

Chesley Taft & Associates first reported a position in AKAO in Q1 2018 and held it in 17 quarters. The position peaked at $234K in Q1 2018. 1 fund tracked by Wall St. Rank holds AKAO as of Q2 2022.

  • Chesley Taft & Associates reported no remaining Achaogen Inc position as of Q2 2022 after selling out during the quarter.
  • Chesley Taft & Associates sold 11,915 Achaogen Inc shares in Q2 2022.
  • Chesley Taft & Associates first reported a position in Achaogen Inc in Q1 2018 and held it in 17 quarters.
  • Chesley Taft & Associates's Achaogen Inc position peaked at $234K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Achaogen Inc as of Q2 2022.

Based on Chesley Taft & Associates's 13F filing for Q2 2022, filed 7 Jul 2022.